Microbiome Disruption and C. diff Recurrence
Understand the gut microbiome and its role in recurrent C. diff infection.
Your gut is home to trillions of microbes—including both good and bad bacteria—that help maintain your overall health. This is called your gut microbiome. It can affect your immunity and nervous system and protect against infection.1-3
When your gut microbiome is disrupted, bad bacteria like C. diff may take over and cause an infection. Sometimes, a C. diff infection can come back more than once. This is called a recurrence.2,4
Antibiotics treat C. diff infection but do not treat the disruption of the gut microbiome. Microbiome disruption increases the risk of C. diff infection recurrence.4,5
REBYOTA is the first and only FDA approved microbiome-based treatment to prevent recurrent C. diff infection, after you’ve already taken antibiotics.12
Receive additional information and resources to help you through your C. diff infection journey.
REBYOTA (fecal microbiota, live – jslm) is indicated for the prevention of recurrence of Clostridioides difficile (C. diff) infection in individuals
18 years of age and older, following antibiotic treatment for recurrent C. diff infection.
Limitation of Use
REBYOTA is not indicated for the treatment of C. diff infection.
You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.FDA.gov/medwatch or call 1-800-332-1088.
Please click to see the full Prescribing Information
The link you have selected will direct you to a site or resource outside of our website.